Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Randall Lee

Clinical Cardiac Electrophysiology San Francisco, CA Medical Doctor

NPI 1316987472 CMS profile 1254719

350 Parnassus Ave Suite 204, Fl 4, San Francisco, CA 94143

Open in the dashboard

General payments

$173,859

164 records reported · program years 2019–2025

Research payments

$5,000

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$211,220 paid to institutions, not to them · program year 2019

Through program year 2025, Randall Lee of San Francisco, CA is reported in the CMS Open Payments database as having received $173,859 across 164 general payments and $5,000 in research payments paid to them. Separately, studies naming them as principal investigator received $211,220 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $41 2
2024 General $293 2
2023 General $16,081 7
2022 General $999 9
2021 General $4,755 35
2020 General $46,660 61
2019 General $105,030 48
2019 Research $5,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Randall Lee
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Randall Lee were reported at $41. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Randall Lee Clinical Cardiac Electrophysiology median Middle half National median
2019 $105,030 $2,361 $585–$8,260 $163
2020 $46,660 $993 $247–$4,351 $114
2021 $4,755 $1,185 $326–$4,739 $132
2022 $999 $2,073 $554–$6,789 $149
2023 $16,081 $2,568 $759–$8,159 $160
2024 $293 $2,557 $703–$7,403 $164
2025 $41 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $95,135 9 payments
  2. Atricure, Inc. $64,668 130 payments
  3. Intuitive Surgical, Inc. $10,800 3 payments
  4. Baylis Medical Company Inc $1,295 1 payment
  5. Abbott Laboratories $1,152 14 payments
  6. Medtronic, Inc. $338 2 payments
  7. Biosense Webster, Inc. $256 2 payments
  8. Biotronik Inc. $147 2 payments
  9. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $68 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Current or prospective ownership or investment interest $89,608 2 payments
  2. Consulting Fee $35,000 7 payments
  3. Travel and Lodging $28,981 68 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,800 4 payments
  5. Food and Beverage $4,471 83 payments
Products named General payments · program years 2019–2025
  1. General Therapies $86,103 1 payment
  2. LARIAT SUTURE DELIVERY DEVICE $43,396 78 payments
  3. Da Vinci Surgical System $10,500 1 payment
  4. VersaCross Access Solution $5,383 6 payments
  5. SYNERGY ABLATION SYSTEM $4,142 25 payments
  6. General - Therapies $3,505 1 payment
  7. NRG needle $1,295 1 payment
  8. EPI-SENSE GUIDED COAGULATION SYS $1,138 7 payments
  9. ATRICURE ATRICLIP LAA EXCLUSION $1,028 5 payments
  10. AMPLATZER $692 3 payments
  11. Other $2,539 37 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Atricure, Inc. $5,000 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

73

Median for Cardiology: 2,533

Drug cost

$32,001

Median for Cardiology: $485,213

Branded share of claims

21.9%

Median for Cardiology: 25.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 16 $23,609
Dofetilide Generic 43 $8,151
Metoprolol Succinate Generic 14 $240

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,782 Part D prescribers listed as Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$69,076

Medicare's payments for the services billed

Medicare patients

625

Average age 76

Services billed

1,344

280 women, 345 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 59%
Arthritis 47%
Heart failure 43%
Chronic kidney disease 42%
Ischemic heart disease 41%
Diabetes 37%
Depression 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

165 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record